InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Organon & Co.

OGN Clue Score37
United States Fiscal year ends December CIK 0001821825
$13.81 +0.44% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $13.81 −58.42% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 14 May 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueNet income
Fiscal year 2019Revenue7.78Net income3.22EPS, diluted12.69Fiscal year 2020Revenue6.53 −16.0%Net income2.16 −32.9%EPS, diluted8.52 −32.9%Fiscal year 2021Revenue6.30 −3.5%Net income1.35 −37.5%EPS, diluted5.31 −37.7%Fiscal year 2022Revenue6.17 −2.1%Net income0.92 −32.1%EPS, diluted3.59 −32.4%Fiscal year 2023Revenue6.26 +1.4%Net income1.02 +11.6%EPS, diluted3.99 +11.1%Fiscal year 2024Revenue6.40 +2.2%Net income0.86 −15.5%EPS, diluted3.33 −16.5%Fiscal year 2025Revenue6.22 −2.9%Net income0.19 −78.4%EPS, diluted0.72 −78.4%
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 7.78 6.53 6.30 6.17 6.26 6.40 6.22
Growth −16.0% −3.5% −2.1% +1.4% +2.2% −2.9%
Net income 3.22 2.16 1.35 0.92 1.02 0.86 0.19
Growth −32.9% −37.5% −32.1% +11.6% −15.5% −78.4%
EPS, diluted 12.69 8.52 5.31 3.59 3.99 3.33 0.72
Growth −32.9% −37.7% −32.4% +11.1% −16.5% −78.4%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginNet margin
Fiscal year 2019Net margin41.4%Free cash flow margin37.6%Fiscal year 2020Net margin33.1%Free cash flow margin31.1%Fiscal year 2021Net margin21.4%Free cash flow margin31.2%Fiscal year 2022Gross margin62.8%Net margin14.9%Free cash flow margin10.7%Fiscal year 2023Gross margin59.8%Net margin16.3%Free cash flow margin8.7%Fiscal year 2024Gross margin58.0%Net margin13.5%Free cash flow margin11.9%Fiscal year 2025Gross margin53.3%Net margin3.0%Free cash flow margin8.7%
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a n/a n/a 62.8% 59.8% 58.0% 53.3%
Net margin 41.4% 33.1% 21.4% 14.9% 16.3% 13.5% 3.0%
Free cash flow margin 37.6% 31.1% 31.2% 10.7% 8.7% 11.9% 8.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow3.02Capital expenditure−0.09Free cash flow2.93Dividends paid0.00Fiscal year 2020Operating cash flow2.28Capital expenditure−0.26Free cash flow2.03 −30.7%Dividends paid0.00Fiscal year 2021Operating cash flow2.16Capital expenditure−0.19Free cash flow1.97 −3.0%Dividends paid−0.15Fiscal year 2022Operating cash flow0.86Capital expenditure−0.20Free cash flow0.66 −66.4%Dividends paid−0.29Fiscal year 2023Operating cash flow0.80Capital expenditure−0.25Free cash flow0.55 −17.2%Dividends paid−0.29Fiscal year 2024Operating cash flow0.94Capital expenditure−0.18Free cash flow0.76 +39.4%Dividends paid−0.30Fiscal year 2025Operating cash flow0.70Capital expenditure−0.16Free cash flow0.54 −29.6%Dividends paid−0.09
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 3.02 2.28 2.16 0.86 0.80 0.94 0.70
Capital expenditure −0.09 −0.26 −0.19 −0.20 −0.25 −0.18 −0.16
Free cash flow 2.93 2.03 1.97 0.66 0.55 0.76 0.54
Growth −30.7% −3.0% −66.4% −17.2% +39.4% −29.6%
Dividends paid 0.00 0.00 −0.15 −0.29 −0.29 −0.30 −0.09

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2019Cash0.00Shareholders’ equity7.04Fiscal year 2020Cash0.01Total debt0.00Net cash (debt)0.01Shareholders’ equity5.49Debt to equity0.00Fiscal year 2021Cash0.74Total debt9.13Net cash (debt)−8.40Shareholders’ equity−1.51Fiscal year 2022Cash0.71Total debt8.91Net cash (debt)−8.21Shareholders’ equity−0.89Fiscal year 2023Cash0.69Total debt8.76Net cash (debt)−8.07Shareholders’ equity−0.07Fiscal year 2024Cash0.68Total debt8.88Net cash (debt)−8.21Shareholders’ equity0.47Debt to equity18.81Fiscal year 2025Cash0.57Total debt8.63Net cash (debt)−8.05Shareholders’ equity0.75Debt to equity11.47
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.00 0.01 0.74 0.71 0.69 0.68 0.57
Total debt n/a 0.00 9.13 8.91 8.76 8.88 8.63
Net cash (debt) n/a 0.01 −8.40 −8.21 −8.07 −8.21 −8.05
Shareholders’ equity 7.04 5.49 −1.51 −0.89 −0.07 0.47 0.75
Debt to equity n/a 0.00 n/a n/a n/a 18.81 11.47

In billions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In billions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
7.78 6.53 6.30 6.17 6.26 6.40 6.22
Growth −16.0% −3.5% −2.1% +1.4% +2.2% −2.9%
2.27 2.12 2.38 2.29 2.52 2.69 2.90
n/a n/a n/a 3.88 3.75 3.72 3.31
Growth −3.4% −0.9% −10.8%
0.22 0.21 0.44 n/a n/a n/a n/a
1.44 1.36 1.67 1.70 1.89 1.76 1.72
3.70 2.75 1.53 1.12 0.67 0.81 0.43
0.39 0.50 0.18 0.21 −0.35 −0.06 0.24
3.22 2.16 1.35 0.92 1.02 0.86 0.19
Growth −32.9% −37.5% −32.1% +11.6% −15.5% −78.4%
Per share
12.69 8.52 5.33 3.61 4.01 3.36 0.72
12.69 8.52 5.31 3.59 3.99 3.33 0.72
Growth −32.9% −37.7% −32.4% +11.1% −16.5% −78.4%
253.5 253.5 253.5 254.1 255.2 257.0 259.5
253.5 253.5 254.2 255.2 256.3 259.2 260.8
Growth +0.0% +0.3% +0.4% +0.4% +1.1% +0.6%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 1.0% a year over five years, and earnings per share fell 39.0% a year.
  • The diluted share count rose 2.9% in five years, which is dilution.
  • Profitable in every one of the 7 years on file.